what to expect after first semaglutide injection in Your Month on What to Expect During the
Description
Les analogues du GLP-1 entranent frquemment des troubles digestifs (nauses, vomissements, diarrhe, constipation) chez environ 73 % des patients sous Wegovy

However, Mathiesen et al

Food and Drug Administration (FDA) has approved two oral GLP-1 options: Wegovy (semaglutide) and Foundayo (orforglipron)

Therefore, people hoping to lose a large percentage of their body weight may need 1.7 mg or 2.4 mg weekly to achieve their goal

Some feel nauseous, tired, bloated, or uninterested in food

Observational comparative effectiveness of pharmaceutical treatments for obesity within the Veterans Health Administration
